Envista Holdings Corporation (NASDAQ:NVST) Receives $32.50 Average PT from Brokerages
Shares of Envista Holdings Corporation (NASDAQ:NVST) have been assigned an average recommendation of “Buy” from the ten ratings firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $32.50.
Several research analysts have recently commented on NVST shares. Bank of America started coverage on shares of Envista in a research note on Monday, October 14th. They set a “neutral” rating on the stock. Goldman Sachs Group began coverage on shares of Envista in a research note on Monday, October 14th. They issued a “buy” rating and a $33.00 price objective for the company. William Blair began coverage on shares of Envista in a report on Monday, October 14th. They issued an “outperform” rating for the company. Robert W. Baird initiated coverage on shares of Envista in a report on Monday, October 14th. They issued an “outperform” rating and a $33.00 price objective for the company. Finally, Stifel Nicolaus assumed coverage on shares of Envista in a research report on Monday, October 14th. They set a “buy” rating and a $34.00 target price on the stock.
In other news, CFO Howard H. Yu acquired 2,000 shares of Envista stock in a transaction dated Friday, September 20th. The stock was acquired at an average cost of $22.00 per share, for a total transaction of $44,000.00. Also, CEO Amir Aghdaei acquired 10,000 shares of Envista stock in a transaction dated Friday, September 20th. The stock was purchased at an average price of $22.00 per share, with a total value of $220,000.00. In the last quarter, insiders have acquired 13,000 shares of company stock worth $286,000.
Shares of NASDAQ NVST traded down $0.08 during trading hours on Tuesday, hitting $27.40. The stock had a trading volume of 1,899,866 shares, compared to its average volume of 1,560,052. The company’s 50-day moving average price is $28.41. Envista has a 52 week low of $25.65 and a 52 week high of $30.80.
Envista (NASDAQ:NVST) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.04. The business had revenue of $659.30 million for the quarter, compared to the consensus estimate of $669.45 million. The firm’s revenue was down 3.0% compared to the same quarter last year.
Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands.
Featured Story: Dividend Aristocrat Index
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.